A summary of professional moves in the clinical trials industry, as well as business news and recognition announcements.
Advanced Clinical, an award-winning clinical development organization, has promoted Julie Ross to President.
Exco InTouch has created a new position for its Valued Partner Network, which now headed by Martin Cook, Vice President for Strategic Partnerships.
INC Research has appointed Judith Ng-Cashin, MD, as Chief Scientific Officer. Dr. Ng-Cashin will be responsible for scientific, medical and ethical governance matters, including collaboration with key medical and scientific stakeholders.
CTI Clinical Trial and Consulting Services has named the following new hires: Felicia Cochran, PhD joins as Associate Director, Regulatory and Scientific Affairs; Yolanda Hill as Patient Recruiter; Beverly Martinez, PhD as Senior Manager, Health Outcomes Research; Jayne Minham as Assistant Director, Clinical Trials; Scott Strassels, PharmD, PhD as Assistant Director, Health Outcomes Research; and Renee Sylvester joins as Regulatory Specialist I.
The company has also promoted Colleen Colson (above left) to Associate Director, Global Quality Assurance, and Matt Hodskins (above right) to Associate Director, Project and Proposal Management.
Greenphire, a provider of global clinical payment solutions, has appointed Wayne Baker as Chief Commercial Officer.
Worldwide Clinical Trials opened a new office at Waterfront House on the Beeston Business Park in Nottingham, housing 185 employees. The company has approximately 1,400 employees in locations around the world, including the UK, United States and Western and Eastern Europe.
WIRB-Copernicus Group announced the publication of "Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees,” in the Journal of Medical Ethics. The paper describes 11 Essential Elements that should be considered for inclusion in a dedicated ethics section in a clinical research protocol, which included input from two of its executives.
Quintiles has been named to Fortune magazine’s “World’s Most Admired Companies” list for 2016, the second year in a row for this distinction. Quintiles is ranked first overall in Fortune’s Healthcare: Pharmacy and Other Services industry category, up from number three in 2015.
PPD announced that Training magazine has named the company for the fifth consecutive year to its Top 125 list of businesses that excel in employee learning and development. In addition, PPD’s training program for clinical research associates (CRAs) received an Outstanding Training Initiative Award.
Clincierge was named a winner of the 2016 Clinical Informatics News Best Practices awards. The company received the award in the category of "Study Startup and Design" in recognition of its efforts related to patient recruitment, support and retention for a rare disease clinical trial. In that study, Clincierge's activities led to a patient dropout rate of less than 5% over 22 months, compared to an industry average of 30% across all clinical trials.
PAREXEL has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting Jobs in 2016 for the third consecutive year. The list recognizes companies with a telecommuting-friendly component to some of their jobs, such as the ability to telecommute entirely or part of the time. PAREXEL offers approximately 20% of its global employees flexible work options, including telecommuting, flexible schedules, and home-based employment.
Quintiles also has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices, as a 2016 World’s Most Ethical Company.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.